Managing Director, Real-World Value & Strategy; Precision & Transformative Medicine
Daryl Spinner, PhD, MBA, is Managing Director of Real World Value and Strategy, and Precision and Transformative Medicine at Evidera | PPD. He brings a background spanning R&D, evidence development, market access, and commercialization for a range of health technologies including small molecule drugs and biologics, regenerative medicines, precision medicines, medical devices, and e-connective technologies. Daryl has served on health policy leadership groups related to HTA, HEOR, and market access, including for ISPOR, AMCP, NAMCP and other professional associations.
Prior to Evidera, Daryl was senior director of managed care and reimbursement at Courtagen Life Sciences, a next generation sequencing-based genetic testing company focused on pediatric and rare disorders. At Courtagen, he developed and led companywide market access and commercial strategies, including engagement with HTA agencies, payers, providers, and customer groups. Prior to Courtagen, he was an associate practice lead and principal consultant at Quintiles Advisory Services, where his specialty included value demonstration and global market access of emerging technologies. Prior to joining Quintiles, Daryl was an associate director in RTI Health Solutions' Market Access and Outcomes Strategy advisory practice helping to build a global market access function for the company.
Before his consulting career, he held the position of research group leader, lab director and faculty at the New York State Institute for Basic Research in Staten Island, New York, where he directed a translational research program covering diagnostics and therapeutics for Alzheimer's, prion disease, and autism spectrum disorders. Daryl earned his BS in chemistry, and a PhD in molecular and cellular pharmacology from the State University of New York at Stony Brook, and an MBA in finance and health sector management from Duke University's Fuqua School of Business.
Monday, September 23
4:00 PM – 5:30 PM